In the summer of 2005, I met several MS patients who were undergoing Solumedrol treatments. I was in the infusion clinic for a release as were several other patients. One patient (I’ll call her Mary), however, was there for a different reason. She had just had a baby.
Before the baby was born, Mary had a plan. She had gone off of her disease-modifying drug (Rebif) when she learned she was pregnant and she planned to breastfeed for a certain period of time before going back on Rebif. ...

